Dietary rice protein isolate attenuates atherosclerosis in apoE-deficient mice by upregulating antioxidant enzymes

Atherosclerosis

Volumn 212, Issue 1, 2010, Pages 107-115

  Burris, Ramona L ^a   Xie, Cheng Hui ^a,b   Thampi, Prajitha ^a,b,c   Wu, Xianli ^a,b   Melnyk, Stepan B ^b   Nagarajan, Shanmugam ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Antioxidant enzymes; Atherosclerosis; Inflammation; Oxidative stress; OxLDL; Rice protein isolate

Indexed keywords

APOLIPOPROTEIN E; CASEIN; CATALASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN; RICE PROTEIN ISOLATE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA SINUS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATTENUATION; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DESCENDING AORTA; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RICE; UPREGULATION;

ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BODY WEIGHT; CASEINS; CATALASE; CHOLESTEROL; CHOLESTEROL, HDL; DIETARY PROTEINS; DISEASE MODELS, ANIMAL; EATING; ENZYMES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; IMMUNOGLOBULIN G; LIPOPROTEINS, LDL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORYZA SATIVA; OXIDATIVE STRESS; PLANT PROTEINS; RNA, MESSENGER; SUPEROXIDE DISMUTASE; UP-REGULATION;

EID: 77956230136     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.05.018     Document Type: Article

References (56)

1. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990, 50:3-23.
2. Kolonel L.N. Variability in diet and its relation to risk in ethnic and migration groups. Basic Life Sci 1988, 43:129-135.
3. Mikkola T.S., Clarkson T.B. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002, 53:605-619.
4. Qureshi A.A., Salser W.A., Parmar R., Emeson E.E. Novel tocotrienols of rice bran inhibit atherosclerotic lesions in C57BL/6 ApoE-deficient mice. J Nutr 2001, 131:2606-2618.
5. Seetharamaiah G.S., Chandrasekhara N. Studies on hypocholesterolemic activity of rice bran oil. Atherosclerosis 1989, 78:219-223.
6. Ling W.H., Cheng Q.X., Ma J., Wang T. Red and black rice decrease atherosclerotic plaque formation and increase antioxidant status in rabbits. J Nutr 2001, 131:1421-1426.
7. Xia X., Ling W., Ma J., et al. An anthocyanin-rich extract from black rice enhances atherosclerotic plaque stabilization in apolipoprotein E-deficient mice. J Nutr 2006, 136:2220-2225.
8. Ni W., Tsuda Y., Takashima S., Sato H., Sato M., Imaizumi K. Anti-atherogenic effect of soya and rice-protein isolate, compared with casein, in apolipoprotein E-deficient mice. Br J Nutr 2003, 90:13-20.
9. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
10. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997, 272:20963-20966.
11. Hsiai T., Berliner J.A. Oxidative stress as a regulator of murine atherosclerosis. Curr Drug Targets 2007, 8:1222-1229.
12. Oliveira H.C., Cosso R.G., Alberici L.C., et al. Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria. FASEB J 2005, 19:278-280.
13. Harrison D., Griendling K.K., Landmesser U., Hornig B., Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003, 91:7A-11A.
14. Greaves D.R., Gordon S. Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J Lipid Res 2005, 46:11-20.
15. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.
16. Caligiuri G., Nicoletti A., Zhou X., Tornberg I., Hansson G.K. Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis 1999, 145:301-308.
17. Reeves P.G., Rossow K.L., Lindlauf J. Development and testing of the AIN-93 purified diets for rodents: results on growth, kidney calcification and bone mineralization in rats and mice. J Nutr 1993, 123:1923-1931.
18. Morita T., Oh-hashi A., Takei K., Ikai M., Kasaoka S., Kiriyama S. Cholesterol-lowering effects of soybean, potato and rice proteins depend on their low methionine contents in rats fed a cholesterol-free purified diet. J Nutr 1997, 127:470-477.
19. Paigen B., Holmes P.A., Mitchell D., Albee D. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c and C3H. Atherosclerosis 1987, 64:215-221.
20. Nagarajan S., Burris R.L., Stewart B.W., Wilkerson J.E., Badger T.M. Dietary soy protein isolate ameliorates atherosclerotic lesions in apolipoprotein E-deficient mice potentially by inhibiting monocyte chemoattractant protein-1 expression. J Nutr 2008, 138:332-337.
21. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
22. Enkhmaa B., Shiwaku K., Katsube T., et al. Mulberry (Morus alba L.) leaves and their major flavonol quercetin 3-(6-malonylglucoside) attenuate atherosclerotic lesion development in LDL receptor-deficient mice. J Nutr 2005, 135:729-734.
23. Wu X., Beecher G.R., Holden J.M., Haytowitz D.B., Gebhardt S.E., Prior R.L. Lipophilic and hydrophilic antioxidant capacities of common foods in the United States. J Agric Food Chem 2004, 52:4026-4037.
24. Melnyk S., Pogribna M., Pogribny I., Hine R.J., James S.J. A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection. J Nutr Biochem 1999, 10:490-497.
25. Thampi P., Stewart B.W., Joseph L., Melnyk S.B., Hennings L.J., Nagarajan S. Dietary homocysteine promotes atherosclerosis in apoE-deficient mice by inducing scavenger receptors expression. Atherosclerosis 2008, 197:620-629.
26. Zhou X., Paulsson G., Stemme S., Hansson G.K. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest 1998, 101:1717-1725.
27. Stewart B.W., Nagarajan S. Recombinant CD36 inhibits oxLDL-induced ICAM-1-dependent monocyte adhesion. Mol Immunol 2006, 43:255-267.
28. Lin S.J., Shyue S.K., Liu P.L., et al. Adenovirus-mediated overexpression of catalase attenuates oxLDL-induced apoptosis in human aortic endothelial cells via AP-1 and C-Jun N-terminal kinase/extracellular signal-regulated kinase mitogen-activated protein kinase pathways. J Mol Cell Cardiol 2004, 36:129-139.
29. Shatrov V.A., Brune B. Induced expression of manganese superoxide dismutase by non-toxic concentrations of oxidized low-density lipoprotein (oxLDL) protects against oxLDL-mediated cytotoxicity. Biochem J 2003, 374:505-511.
30. Van Tits L., De Graaf J., Hak-Lemmers H., et al. Increased levels of low-density lipoprotein oxidation in patients with familial hypercholesterolemia and in end-stage renal disease patients on hemodialysis. Lab Invest 2003, 83:13-21.
31. Tabuchi M., Inoue K., Usui-Kataoka H., et al. The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis. J Lipid Res 2007, 48:768-781.
32. Kato R., Mori C., Kitazato K., et al. Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2009, 29:33-39.
33. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004, 84:1381-1478.
34. Yu S., Fang N., Li Q., et al. In vitro actions on human cancer cells and the liquid chromatography-mass spectrometry/mass spectrometry fingerprint of phytochemicals in rice protein isolate. J Agric Food Chem 2006, 54:4482-4492.
35. Rosenblat M., Aviram M. Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL: in vitro and in vivo studies. Free Radic Biol Med 1998, 24:305-317.
36. Rosenblat M., Coleman R., Aviram M. Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 2002, 163:17-28.
37. Faruqi R.M., Poptic E.J., Faruqi T.R., De La Motte C., DiCorleto P.E. Distinct mechanisms for N-acetylcysteine inhibition of cytokine-induced E-selectin and VCAM-1 expression. Am J Physiol 1997, 273:H817-H826.
38. Dedoussis G.V., Kaliora A.C., Psarras S., et al. Antiatherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expression. Atherosclerosis 2004, 174:293-303.
39. Ashfaq S., Abramson J.L., Jones D.P., et al. The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol 2006, 47:1005-1011.
40. Qiao M., Kisgati M., Cholewa J.M., et al. Increased expression of glutathione reductase in macrophages decreases atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2007, 27:1375-1382.
41. Fang X., Weintraub N.L., Rios C.D., et al. Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells. Circ Res 1998, 82:1289-1297.
42. Yang H., Roberts L.J., Shi M.J., et al. Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ Res 2004, 95:1075-1081.
43. Lewis P., Stefanovic N., Pete J., et al. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation 2007, 115:2178-2187.
44. Torzewski M., Ochsenhirt V., Kleschyov A.L., et al. Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2007, 27:850-857.
45. Guo Z., Ran Q., Roberts L.J., et al. Suppression of atherogenesis by overexpression of glutathione peroxidase-4 in apolipoprotein E-deficient mice. Free Radic Biol Med 2008, 44:343-352.
46. Yang H., Shi M., Richardson A., Vijg J., Guo Z. Attenuation of leukocyte-endothelium interaction by antioxidant enzymes. Free Radic Biol Med 2003, 35:266-276.
47. Kume N., Cybulsky M.I., Gimbrone M.A. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992, 90:1138-1144.
48. Murohara T., Scalia R., Lefer A.M. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res 1996, 78:780-789.
49. Quinn M.T., Parthasarathy S., Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA 1988, 85:2805-2809.
50. Liu-Wu Y., Hurt-Camejo E., Wiklund O. Lysophosphatidylcholine induces the production of IL-1beta by human monocytes. Atherosclerosis 1998, 137:351-357.
51. Zembowicz A., Tang J.L., Wu K.K. Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine. J Biol Chem 1995, 270:17006-17010.
52. Hirata K., Miki N., Kuroda Y., Sakoda T., Kawashima S., Yokoyama M. Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ Res 1995, 76:958-962.
53. Sheikh A.M., Ochi H., Manabe A., Masuda J. Lysophosphatidylcholine posttranscriptionally inhibits interferon-gamma-induced IP-10, Mig and I-Tac expression in endothelial cells. Cardiovasc Res 2005, 65:263-271.
54. Hara S., Shike T., Takasu N., Mizui T. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells. Arterioscler Thromb Vasc Biol 1997, 17:1258-1266.
55. Hou M., Xia M., Zhu H., et al. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARgamma-LXRalpha-ABCA1-dependent pathway associated with apoE. Cell Biochem Funct 2007, 25:33-44.
56. Adams M.R., Golden D.L., Franke A.A., Potter S.M., Smith H.S., Anthony M.S. Dietary soy beta-conglycinin (7S globulin) inhibits atherosclerosis in mice. J Nutr 2004, 134:511-516.